PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.

EMBO Mol Med · 2017 · PMC5286375 · PMID 27932443

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The combination of anti‐PD‐L1 with gemcitabine produced a marginally significant tumor growth delay, whereas gemcitabine and RT had a more pronounced effect.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.